Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) reported Q2 EPS of ($1.02), $0.42 worse than the analyst estimate of ($0.60). Revenue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE